Pharmaron Ningbo Campus Opening Ceremony
November 6, 2017 l Ningbo Site
On Friday, November 3, 2017, Pharmaron held its official opening of the Ningbo-Hangzhou Bay campus. This site will be integrated with Pharmaron’s global R&D service platform and has capacity for thousands of scientists to provide R&D services to partners around the world. The location allows Pharmaron the ability to tap into the talent pool in the Greater Shanghai region and also interact with clients in the region with ease. This new campus will be a twin to the established campus in Beijing. The opening ceremony was witnessed by hundreds of attendees, including local government officials, fellows of Chinese Academy of Sciences, invited guest speakers from academia and industry around the world, representatives from Pharmaron’s partners and Pharmaron staff.
- Prof. Qilin Zhou, Nankai University: The Privileged Chiral Spiro Catalysts
- Dr. Rob Geertman, Janssen Research and Development: Missing a Solvate in Late Development
- Dr. Michael Kress, Merck Sharp & Dohme: Adventures at the Interfaces of Chemistry: Product Discovery and Development at MSD
- Dr. Michael Varney, Genentech: Drug Discovery and Development at Genentech
- Dr. Stevan Djuric, AbbVie: The Utility of Enabling Chemistry Technology in Pharmaceutical R&D
- Dr. Sergii Pazenok, Bayer AG: A General Approach Towards the Heterocyclic Compounds Bearing Emergent Fluorinated Substituents
- Dr. Helmut Haning, Bayer AG: Discovery of Molidustat, a Novel Inhibitor of HIF Propyl Hydroxylase
- Dr. Peter Toogood, Lycera: Three Decades of Cancer Drug Discovery
- Prof. Darren Dixon, University of Oxford: Catalytic Approaches to Simplifying Synthesis